Chymopapain treatment of intervertebral disc disease.

Abstract

In the first of a two-part study, the authors review the known biochemical, pharmacological, toxicological, and experimental data concerning chymopapain and the intervertebral disc. They describe the action of this proteolytic enzyme, which apparently disrupts the protein mucopolysaccharide component of disc material, most marked in the nucleus pulposus. A rapid conversion to collagen causes a loss of disc space height; toxicity appears to result from alteration of bonding between capillary endothelial cells that in turn produces hemorrhage. Part 2 reviews significant reported results and complications of clinical chemonucleolysis.

Statistics

0100200'89'92'95'98'01'04'07'10'13'16
Citations per Year

153 Citations

Semantic Scholar estimates that this publication has 153 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Watts1975ChymopapainTO, title={Chymopapain treatment of intervertebral disc disease.}, author={Clark Watts and Robin Knighton and G E Roulhac}, journal={Journal of neurosurgery}, year={1975}, volume={42 4}, pages={374-83} }